Predictive molecular signatures for successful tapering of canakinumab in systemic juvenile idiopathic arthritis.

Ilaris (canakinumab) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42772990

Andreas Huge; Christoph Kessel; Christopher J Farady; Claas H Hinze; Dirk Foell; Emely L Verweyen; Marcel Trautmann; Melanie Saers; Sabrina Fuehner; Susanne Schleifenbaum; Suzanne McCreddin; Tanja Hinze; Wolfgang Hartmann

Sep 23, 2026